These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 31109441)
1. [Prognostic Analysis of EGFR-TKIs Combined with Gamma Knife in EGFR-mutant Lung Adenocarcinoma with Brain Metastasis]. Chen L; Fu M; Zhou J; Yao Y; Zhou J Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):312-318. PubMed ID: 31109441 [TBL] [Abstract][Full Text] [Related]
2. Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis. Chen Y; Wei J; Cai J; Liu A BMC Cancer; 2019 Aug; 19(1):793. PubMed ID: 31399067 [TBL] [Abstract][Full Text] [Related]
3. The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901-EGFR-TKI). Yomo S; Serizawa T; Yamamoto M; Higuchi Y; Sato Y; Shuto T; Akabane A; Jokura H; Kawagishi J; Aoyama H J Neurooncol; 2019 Oct; 145(1):151-157. PubMed ID: 31487030 [TBL] [Abstract][Full Text] [Related]
4. Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patients. Yomo S; Oda K Lung Cancer; 2018 May; 119():120-126. PubMed ID: 29656746 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases. Ke SB; Qiu H; Chen JM; Shi W; Chen YS Curr Med Sci; 2018 Dec; 38(6):1062-1068. PubMed ID: 30536070 [TBL] [Abstract][Full Text] [Related]
6. Value and significance of brain radiation therapy during first-line EGFR-TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique. Gu Y; Xu Y; Zhuang H; Jiang W; Zhang H; Li X; Liu Y; Ma L; Zhao D; Cheng Y; Yu Y; Liu P; Qin J; Chen X; Gao J; Wang M; Liang L; Cao B Thorac Cancer; 2021 Dec; 12(23):3157-3168. PubMed ID: 34651449 [TBL] [Abstract][Full Text] [Related]
7. Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy. Shen CI; Huang HC; Chiang CL; Luo YH; Shiao TH; Chiu CH Lung Cancer; 2019 Dec; 138():52-57. PubMed ID: 31634655 [TBL] [Abstract][Full Text] [Related]
9. Clinical research on stereotactic radiosurgery combined with epithermal growth factor tyrosine kinase inhibitors in the treatment of brain metastasis of non-small cell lung cancer. Jia F; Cheng X; Zeng H; Miao J; Hou M J BUON; 2019; 24(2):578-584. PubMed ID: 31128009 [TBL] [Abstract][Full Text] [Related]
10. Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs. Zhou F; Ma W; Li W; Ni H; Gao G; Chen X; Zhang J; Shi J BMC Cancer; 2018 Oct; 18(1):1033. PubMed ID: 30352571 [TBL] [Abstract][Full Text] [Related]
11. First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor alone or with whole-brain radiotherapy for brain metastases in patients with EGFR-mutated lung adenocarcinoma. Chen Y; Yang J; Li X; Hao D; Wu X; Yang Y; He C; Wang W; Wang J Cancer Sci; 2016 Dec; 107(12):1800-1805. PubMed ID: 27627582 [TBL] [Abstract][Full Text] [Related]
12. Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients. Hsiao SH; Lin HC; Chou YT; Lin SE; Kuo CC; Yu MC; Chung CL Lung Cancer; 2013 Sep; 81(3):455-461. PubMed ID: 23871711 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis. Byeon S; Ham JS; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ Med Oncol; 2016 Aug; 33(8):97. PubMed ID: 27447711 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant. Zhao L; Cai X; Chen D; Ye X; Gao M; Lu L; Su H; Su M; Hou M; Xie C Radiat Oncol; 2019 Dec; 15(1):3. PubMed ID: 31892337 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring Epidermal Growth Factor Receptor Mutations. Hu F; Xu J; Zhang B; Li C; Nie W; Gu P; Hu P; Wang H; Zhang Y; Shen Y; Wang S; Zhang X Clin Lung Cancer; 2019 Jan; 20(1):e81-e90. PubMed ID: 30341018 [TBL] [Abstract][Full Text] [Related]
16. [Plasma relative abundance of epidermal growth factor receptor mutations predicts clinical response to epidermal growth factor receptor-tyrosine kinase inhibitors in patients with advanced lung adenocarcinoma]. Xu HY; Lai QQ; Su SS; Zhou LP; Ye JR; Zhang DQ; Xie YP; Li YP Zhonghua Nei Ke Za Zhi; 2019 Jan; 58(1):49-55. PubMed ID: 30605951 [No Abstract] [Full Text] [Related]
17. A comparative analysis of EGFR mutation status in association with the efficacy of TKI in combination with WBRT/SRS/surgery plus chemotherapy in brain metastasis from non-small cell lung cancer. Cai L; Zhu JF; Zhang XW; Lin SX; Su XD; Lin P; Chen K; Zhang LJ J Neurooncol; 2014 Nov; 120(2):423-30. PubMed ID: 25098700 [TBL] [Abstract][Full Text] [Related]
18. Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma. Ma X; Zhu H; Guo H; Han A; Wang H; Jing W; Zhang Y; Kong L; Yu J Oncotarget; 2016 Dec; 7(49):81906-81917. PubMed ID: 27626317 [TBL] [Abstract][Full Text] [Related]
19. Survival outcome assessed according to tumor burden and progression patterns in patients with epidermal growth factor receptor mutant lung adenocarcinoma undergoing epidermal growth factor receptor tyrosine kinase inhibitor therapy. Cha YK; Lee HY; Ahn MJ; Choi YL; Lee JH; Park K; Lee KS Clin Lung Cancer; 2015 May; 16(3):228-36. PubMed ID: 25499173 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the Efficacy of EGFR-TKIs Combined With Radiotherapy in Advanced Lung Adenocarcinoma Patients With EGFR Mutation: A Retrospective Study. Wang Y; Yu W; Shi J; Qiu R; Jiang N; Wang Z; Yang J; Jia Z; Song M Technol Cancer Res Treat; 2022; 21():15330338221100358. PubMed ID: 35607295 [No Abstract] [Full Text] [Related] [Next] [New Search]